121 related articles for article (PubMed ID: 38432099)
1. Thyroid dysfunction after immune checkpoint inhibitors in a single-centre UK pan-cancer cohort: A retrospective study.
Kennedy OJ; Ali N; Lee R; Monaghan P; Adam S; Cooksley T; Lorigan P
Eur J Cancer; 2024 May; 202():113949. PubMed ID: 38432099
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
3. The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function.
Tsai K; Ma H; Liang TZ; Xing Y; Chung S; Dorff T; Bell D; Lechner MG
Thyroid; 2024 Feb; 34(2):158-166. PubMed ID: 38069567
[No Abstract] [Full Text] [Related]
4. Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer.
Zhou Y; Xia R; Xiao H; Pu D; Long Y; Ding Z; Liu J; Ma X
Int Immunopharmacol; 2021 Feb; 91():107296. PubMed ID: 33360368
[TBL] [Abstract][Full Text] [Related]
5. Changes in thyroid function and evolution of subclinical thyroid disease in older men.
Tan SY; Chubb SAP; Flicker L; Almeida OP; Golledge J; Hankey GJ; Yeap BB
Clin Endocrinol (Oxf); 2024 Feb; 100(2):170-180. PubMed ID: 38059618
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
[TBL] [Abstract][Full Text] [Related]
7. BASELINE TSH LEVEL IS ASSOCIATED WITH RISK OF ANTI-PD-1-INDUCED THYROID DYSFUNCTION.
Pollack RM; Kagan M; Lotem M; Dresner-Pollak R
Endocr Pract; 2019 Aug; 25(8):824-829. PubMed ID: 31013164
[No Abstract] [Full Text] [Related]
8. Subclinical thyroid dysfunction and fracture risk: a meta-analysis.
Blum MR; Bauer DC; Collet TH; Fink HA; Cappola AR; da Costa BR; Wirth CD; Peeters RP; Åsvold BO; den Elzen WP; Luben RN; Imaizumi M; Bremner AP; Gogakos A; Eastell R; Kearney PM; Strotmeyer ES; Wallace ER; Hoff M; Ceresini G; Rivadeneira F; Uitterlinden AG; Stott DJ; Westendorp RG; Khaw KT; Langhammer A; Ferrucci L; Gussekloo J; Williams GR; Walsh JP; Jüni P; Aujesky D; Rodondi N;
JAMA; 2015 May; 313(20):2055-65. PubMed ID: 26010634
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
10. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
Luongo C; Morra R; Gambale C; Porcelli T; Sessa F; Matano E; Damiano V; Klain M; Schlumberger M; Salvatore D
J Endocrinol Invest; 2021 Sep; 44(9):1927-1933. PubMed ID: 33576954
[TBL] [Abstract][Full Text] [Related]
11. Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis.
van Vliet NA; van Heemst D; Almeida OP; Åsvold BO; Aubert CE; Bae JB; Barnes LE; Bauer DC; Blauw GJ; Brayne C; Cappola AR; Ceresini G; Comijs HC; Dartigues JF; Degryse JM; Dullaart RPF; van Eersel MEA; den Elzen WPJ; Ferrucci L; Fink HA; Flicker L; Grabe HJ; Han JW; Helmer C; Huisman M; Ikram MA; Imaizumi M; de Jongh RT; Jukema JW; Kim KW; Kuller LH; Lopez OL; Mooijaart SP; Moon JH; Moutzouri E; Nauck M; Parle J; Peeters RP; Samuels MH; Schmidt CO; Schminke U; Slagboom PE; Stordal E; Vaes B; Völzke H; Westendorp RGJ; Yamada M; Yeap BB; Rodondi N; Gussekloo J; Trompet S;
JAMA Intern Med; 2021 Nov; 181(11):1440-1450. PubMed ID: 34491268
[TBL] [Abstract][Full Text] [Related]
12. The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study.
Aubert CE; Bauer DC; da Costa BR; Feller M; Rieben C; Simonsick EM; Yaffe K; Rodondi N;
Clin Endocrinol (Oxf); 2017 Nov; 87(5):617-626. PubMed ID: 28850708
[TBL] [Abstract][Full Text] [Related]
13. Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors.
von Itzstein MS; Gonugunta AS; Wang Y; Sheffield T; Lu R; Ali S; Fattah FJ; Xie D; Cai J; Xie Y; Gerber DE
Cancer Immunol Immunother; 2022 Sep; 71(9):2169-2181. PubMed ID: 35072744
[TBL] [Abstract][Full Text] [Related]
14. Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis.
Yang P; Shen G; Zhang H; Zhang C; Li J; Zhao F; Li Z; Liu Z; Wang M; Zhao J; Zhao Y
Int Immunopharmacol; 2024 May; 133():111961. PubMed ID: 38608442
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
Kotwal A; Kottschade L; Ryder M
Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
[No Abstract] [Full Text] [Related]
17. Immune Checkpoint Inhibitor-induced Thyroid Disorders: A Single Center Experience.
Patrizio A; Fallahi P; Antonelli A; Ferrari SM
Curr Pharm Des; 2023; 29(4):295-299. PubMed ID: 35593347
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.
Lu D; Yao J; Yuan G; Gao Y; Zhang J; Guo X
Oncologist; 2022 Mar; 27(2):e126-e132. PubMed ID: 35641200
[TBL] [Abstract][Full Text] [Related]
19. Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort.
Laulund AS; Nybo M; Brix TH; Abrahamsen B; Jørgensen HL; Hegedüs L
PLoS One; 2014; 9(10):e110437. PubMed ID: 25340819
[TBL] [Abstract][Full Text] [Related]
20. Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis.
Toloza FJK; Derakhshan A; Männistö T; Bliddal S; Popova PV; Carty DM; Chen L; Taylor P; Mosso L; Oken E; Suvanto E; Itoh S; Kishi R; Bassols J; Auvinen J; López-Bermejo A; Brown SJ; Boucai L; Hisada A; Yoshinaga J; Shilova E; Grineva EN; Vrijkotte TGM; Sunyer J; Jiménez-Zabala A; Riaño-Galan I; Lopez-Espinosa MJ; Prokop LJ; Singh Ospina N; Brito JP; Rodriguez-Gutierrez R; Alexander EK; Chaker L; Pearce EN; Peeters RP; Feldt-Rasmussen U; Guxens M; Chatzi L; Delles C; Roeters van Lennep JE; Pop VJM; Lu X; Walsh JP; Nelson SM; Korevaar TIM; Maraka S
Lancet Diabetes Endocrinol; 2022 Apr; 10(4):243-252. PubMed ID: 35255260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
